NCT06361901

Brief Summary

Our study will provide precise and intensive speech rehabilitation treatment program to patients with speech disorders after stroke, and compare clinical evaluations with the conventional speech therapy patient group. Clinical evaluation tools will be performed before and after the treatment for all patients

  • K-Western Aphasia Battery for aphasia assessment tools
  • Cerebral blood flow changes with near-infrared spectroscopy

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 17, 2023

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

November 27, 2023

Completed
5 months until next milestone

First Posted

Study publicly available on registry

April 12, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

April 12, 2024

Status Verified

April 1, 2024

Enrollment Period

1 year

First QC Date

November 27, 2023

Last Update Submit

April 11, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Aphasic quatient

    Aphasic quatient using K-Western Aphasia Battery for aphasia assessment tools

    Evaluate two times ; Before speech therapy treatment program (baseline) and within 7days after the treatment period.

Secondary Outcomes (1)

  • Change of cerebral blood flow

    Evaluate two times ; Before speech therapy treatment program (baseline) and within 7days after the treatment period.

Study Arms (2)

Language therapy group with language rehabilitation program

EXPERIMENTAL

In addition to 5-session conventional language therapy, we provide a 5-session language rehabilitation program using an AI-based computerized cognitive and language training program. A cognitive evaluation is conducted before starting treatment, and K-Western Aphasia Battery and Functional Near infrared spectroscopy are performed before and after the treatment.

Device: Zenicog;language rehabilitation programProcedure: Conventional language rehabilitation

Conventional language therapy group

ACTIVE COMPARATOR

We provide a 10-session conventional language therapy. A cognitive evaluation is conducted before starting treatment, and K-Western Aphasia Battery and Functional Near infrared spectroscopy are performed before and after the treatment.

Procedure: Conventional language rehabilitation

Interventions

This program is an AI-based computerized cognitive and language training program.

Language therapy group with language rehabilitation program

Conventional language rahabilitation therapy will apply for all participants with speech impairement

Conventional language therapy groupLanguage therapy group with language rehabilitation program

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults over 19 years old
  • Those with speech disorders that occurred after a stroke was diagnosed
  • Those who can follow the clinical study procedures
  • Those who voluntarily signed the consent form

You may not qualify if:

  • Patients who have difficulty to consent to research and participate in speech rehabilitation programs due to cognitive decline

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Rehabilitation Medicine, Korea University Guro Hospital

Seoul, 08308, South Korea

RECRUITING

MeSH Terms

Conditions

StrokeAphasiaCommunication Disorders

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesSpeech DisordersLanguage DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental Disorders

Central Study Contacts

Seung Nam Yang, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 27, 2023

First Posted

April 12, 2024

Study Start

November 17, 2023

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

April 12, 2024

Record last verified: 2024-04

Locations